Ligand raises EPS guidance floor, closes XOMA Royalty deal, reports pipeline progressAug 6Quarterly updateLigand Pharmaceuticals Inc
Travere reports Q2 2026 results as FSGS launch begins and civorebrutinib deal closesAug 4Quarterly updatepegtibatinasesparsentan
Sign inSign in